Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KB 2796

Known as: KB-2796 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
NMDA receptor antagonists have been demonstrated to be neuroprotective in focal cerebral ischemia and are supposed to prevent… Expand
Is this relevant?
1998
1998
Abstract NMDA receptor antagonists have been demonstrated to be neuroprotective in focal cerebral ischemia and are supposed to… Expand
Is this relevant?
1998
1998
KB-2796, a novel calcium channel blocker, is under development as an anti-migraine drug. We examined its effects on spreading… Expand
Is this relevant?
1994
1994
The effects of KB-2796, a new Ca(2+)-channel blocker, on 5-hydroxytryptamine (5-HT)-induced responses were investigated in… Expand
Is this relevant?
1993
1993
1. The effects of KB-2796, a new diphenylpiperazine calcium antagonist, on the mitochondrial dysfunction and energy metabolism… Expand
Is this relevant?
1993
1993
The effects of KB-2796, 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4- trimethoxybenzyl)piperazine-2HCl, on the low- and high-voltage… Expand
Is this relevant?
1993
1993
The effects of the novel calcium channel antagonist KB-2796, other calcium channel antagonists, an N-methyl-D-aspartate (NMDA… Expand
Is this relevant?
1991
1991
The anti-platelet activity of KB-2796, 1-[bis(4-fluorophenyl)methyl]-4- (2,3,4-trimethoxybenzyl) piperazine dihydrochloride, was… Expand
Is this relevant?
1989
1989
The effects of a new calcium channel blocker, 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)-piperazine dihydrochloride… Expand
Is this relevant?
1988
1988
The effect of KB-2796, a new diphenylpiperazine calcium antagonist, on [3H]nitrendipine ([3H]NTD) binding was investigated in… Expand
Is this relevant?